Endocrine Changes in Patients on Chronic Dialysis

  • James P. Knochel


Patients with end-stage renal disease display a variety of endocrine disturbances. In some instances, clearly recognizable endocrinopathies occur. More commonly, evidence of endocrine dysfunction consists only of laboratory abnormalities. Many of these are not associated with apparent disease.


Growth Hormone LUTEINIZING Hormone Chronic Renal Failure Chronic Hemodialysis Chronic Dialysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Samaan NA, Freeman RM: Growth hormone levels in severe renal failure. Metabolism 19: 102, 1970PubMedCrossRefGoogle Scholar
  2. 2.
    Collipp PJ, Patrick JR, Goodheart C, Kaplan SA: Distribution of tritium-labelled human growth hormone in rats and guines pigs. Proc Soc Exp Biol Med 121: 173, 1966PubMedGoogle Scholar
  3. 3.
    Bala RM, Beck JC: Human growth hormone in urine. J Clin Endocrinol Metab 33: 799, 1971PubMedCrossRefGoogle Scholar
  4. 4.
    Bergström J, Fürst P, Josephson B, Noree LO: Factors affecting the nitrogen balance in chronic uremic patients receiving essential amino acids intravenously or by mouth. Nutr Metab 14: (suppl) 162, 1972PubMedCrossRefGoogle Scholar
  5. 5.
    Spitz I, Rubenstein AH, Bersohn I, Lawrence AM, Kirsteins L: The effect of dialysis on the carbohydrate intolerance of chronic renal failure. Horm Metab Res 2: 86, 1970PubMedCrossRefGoogle Scholar
  6. 6.
    Davidson MB, Fisher MB, Dabir-Vaziri N, Schaffer M: Effect of protein intake and dialysis on the abnormal growth hormone, glucose and insulin homeostasis in uremia. Metabolism 25: 455, 1976PubMedCrossRefGoogle Scholar
  7. 7.
    Bala RM, Ferguson KA, Beck JC: Plasma biological and immunoreactive human growth hormone-like activity. Endocrinology 87: 506, 1970PubMedCrossRefGoogle Scholar
  8. 8.
    Lewy JE, New MI: Growth in children with renal failure. Am J Med 58: 65, 1975PubMedCrossRefGoogle Scholar
  9. 9.
    Saenger R, Wiedman E, Schwartz E, Korth-Schutz S, Lewy JE, Riggio RR, Rubin AL, Stenzel KH, New MI: Somatomedin and growth after renal transplantation. Pediatr Res 8: 163, 1974PubMedGoogle Scholar
  10. 10.
    Pennisi AJ, Phillips LS, Uittenbogaart C, Ettenger RB, Malekyadeh MH, Fine RM: Nutritional intake, somatomedin activity and linear growth in children undergoing hemodialysis. Am Soc Nephrol (Abstract) 9: 37, 1976Google Scholar
  11. 11.
    Takano K, Hall K, Ritzen M, Iselius L, Sievertsson H: Somatomedin A in human serum, determined by radioreceptor assay. Acta Endocrinol (Kbh) 82: 449, 1976Google Scholar
  12. 12.
    Marcovitz S, Friesen H: Regulation of prolactin secretion in man. Clin Res 19: 773, 1971Google Scholar
  13. 13.
    LeFebvre P, Luyckx AS, Nizet A: Kidney function as a major factor regulating peripheral glucagon levels. Diabetes (suppl) 1, 23: 343, 1974Google Scholar
  14. 14.
    Turkington RW: Human prolactin. Am J Med 53: 389, 1972PubMedCrossRefGoogle Scholar
  15. 15.
    Guevara A, Vidt D, Hallbert MC, Zorn EM, Pohlman C, Weiland RC: Serum gonadotrophin and testosterone levels in uremic males undergoing intermittent dialysis. Ann Intern Med 69: 73, 1968Google Scholar
  16. 16.
    Sawin CT, Longcope C, Schmitt GW, Ryan RJ: Blood levels of gonadotropins and gonadal hormones in gynecomastia associated with chronic hemodialysis. J Clin Endocrinol Metab 36: 988, 1973PubMedCrossRefGoogle Scholar
  17. 17.
    Lindsay RM, Briggs JD, Luke RG, Boyle IT, Kennedy AC: Gynaecomastia in chronic renal failure. Br Med J 4: 779, 1967PubMedCrossRefGoogle Scholar
  18. 18.
    Freeman RM, Lawton RL, Fearing MO: Gynecomastia: An endocrinologic complication of hemodialysis. Ann Intern Med 69: 67, 1968PubMedGoogle Scholar
  19. 19.
    Schmitt, GW, Shehadeh I, Sawin CT: Transient gynecomastia in chronic renal failure during chronic intermittent hemodialysis. Ann Intern Med 69: 73, 1968PubMedGoogle Scholar
  20. 20.
    Feldman HA, Singer I: Endocrinology and metabolism in uremia and dialysis: A clinical review. Medicine 54: 345, 1974CrossRefGoogle Scholar
  21. 21.
    Chen JC, Vidt DG, Zorn EM, Hallbert MC, Wieland RG: Pituitary-Leydig cell function in uremic males. J Clin Endocrinol Metab 31: 14, 1970PubMedCrossRefGoogle Scholar
  22. 22.
    Distiller LA, Morley JE, Sagel J, Pokroy MM, Robkin, R: Pituitary-gonadal function in chronic renal failure: The effect of luteinizing hormone-releasing hormone and the influence of dialysis. Metabolism 24: 711, 1975PubMedCrossRefGoogle Scholar
  23. 23.
    Stewart-Bentley M, Gans D, Horton R: Regulation of gonadal function in uremia. Metabolism 23: 1065, 1974PubMedCrossRefGoogle Scholar
  24. 24.
    Unzelman RF, Alderfer GR, Chojnacki RE: Pregnancy and chronic hemodialysis. Trans Am Soc Artif Intern Organs 19: 144, 1974CrossRefGoogle Scholar
  25. 25.
    Mackay EV: Pregnancy and renal disease. Aust NZ J Obstet Gynaecol 3: 21, 1963CrossRefGoogle Scholar
  26. 26.
    Schmidt P, Strobaeus N, Prame G, Schittek F: Exophthalmos in chronic renal insufficiency. Scand J Urol Nephrol 5: 146, 1971PubMedCrossRefGoogle Scholar
  27. 27.
    Ramirez G, Jubiz W, Gutch CF, Bloomer HA, Siegler R, Kolff WJ: Thyroid abnormalities in renal failure. Ann Intern Med 79: 500, 1973PubMedGoogle Scholar
  28. 28.
    Gonzalez-Barcena D, Kastin AK, Schalch DS, Torres-Zamora M, Perrez-Pasten E, Kato A, Schally AV: Responses to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men. J Clin Endocrinol Metab 36: 117, 1973PubMedCrossRefGoogle Scholar
  29. 29.
    Redding TW, Schally AY: On the half-life of thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men. Neurendocrinology 9: 252, 1972Google Scholar
  30. 30.
    Fine A, Thomson RM, Jones JV, Murray RG, Tweedle A, Gray CE: The renal handling of insulin and thyroid hormones in normal man. Clin Sci Mol Med 50: 435, 1975Google Scholar
  31. 31.
    Ramirez G, O’Neill, W Jr, Jubiz W, Bloomer HA: Thyroid dysfunction in uremia: Evidence for thyroid and hypophyseal abnormalities. Ann Intern Med 84: 672, 1976PubMedGoogle Scholar
  32. 32.
    Silverberg DS, Ulan RA, Fawcett DM, Dossetor JB, Grace M, Bettcher K: Effects of chronic hemodialysis on thyroid function in chronic renal failure. Can Med Assoc J 109: 282, 1973PubMedGoogle Scholar
  33. 33.
    Oddie TH, Flanigan WJ, and Fisher DA: Iodine and thyroxine metabolism in anephric patients receiving chronic peritoneal dialysis. J Clin Endocrinol Metab 31: 277, 1970PubMedCrossRefGoogle Scholar
  34. 34.
    Hollander CS, Scott RL, Burgess JA, Rabinowitz D, Merimee JJ, Oppenheimer JH: Free fatty acid: a possible regulator of free thyroid hormone levels in man. J Clin Endocrinol Metab 27: 1219, 1967PubMedCrossRefGoogle Scholar
  35. 35.
    Hershman JM, Jones CM, Bailey AL: Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin. J Clin Endocrinol Metab 34: 574, 1972CrossRefGoogle Scholar
  36. 36.
    Shatz DL: Serum free thyroxine and thyroxine binding protein studies in patients with supraventricular tachycardia. J Clin Endocrinol Metab 27: 165, 1967CrossRefGoogle Scholar
  37. 37.
    Bricker NS, Hlad CJ Jr: Observations on the renal clearance of I. J Clin Invest 34: 1057, 1955PubMedCrossRefGoogle Scholar
  38. 38.
    Koutras DA, Marketos FG, Rigopoulos GA, Malamos B: Iodine, metabolism and chronic renal insufficiency. Nephron 9: 55, 1972PubMedCrossRefGoogle Scholar
  39. 39.
    Korman MC, Laver MC, Hansky J: Hypergastrinaemia in chronic renal failure. Br Med J 1: 209, 1972PubMedCrossRefGoogle Scholar
  40. 40.
    Clendinnen DG, Davison WD, Lemmi CA, Jackson BM: Renal uptake and excretion of gastrin in the dog. Gastroenterology 58: 935, 1970Google Scholar
  41. 41.
    Davidson, WD, Corredor JS, Bassist L: A cause of fasting hypergastrinemia. Clin Res 19: 390, 1971Google Scholar
  42. 42.
    Gordon EM, Johnson AG, Williams G: Gastric assessment of prospective renal transplant patients. Lancet 1: 226, 1972PubMedCrossRefGoogle Scholar
  43. 43.
    Sheperd AMM, Stewart WK, Wormsley KG: Peptic ulceration in chronic renal failure. Lancet 1: 1357, 1973CrossRefGoogle Scholar
  44. 44.
    Dent RI, James JH, Wang C, Deftos LJ, Talamo R, Fischer J: Hyperparathyroidism: Gastric acid secretion and gastrin. Ann Surg 176: 360, 1972PubMedCrossRefGoogle Scholar
  45. 45.
    Englert E Jr, Brown H, Williamson DG, Wallach S, Simmons EL: Metabolism of free and conjugated 17- hydroxycorticosteroids in subjects with uremia. J Clin Endocrinol Metab 18: 36, 1958PubMedCrossRefGoogle Scholar
  46. 46.
    Bacon EG, Kenney FM, Murdaugh HV, Richards C: Prolonged serum half-life of Cortisol in renal failure. Johns Hopkins Med J 132: 127, 1973PubMedGoogle Scholar
  47. 47.
    Mishkin MS, Hsu JH, Walker WG, Bledsoe T: Studies on the episodic secretion of Cortisol in uremic patients on hemodialysis. Johns Hopkins Med J 131: 160, 1972PubMedGoogle Scholar
  48. 48.
    Barbour GL, Sevier BR: Adrenal responsiveness in chronic hemodialysis. N Engl J Med 290: 1258, 1974PubMedGoogle Scholar
  49. 49.
    Weidmann P, Horton R, Maxwell MH, Franklin SS, Fichman M: Dynamic studies of aldosterone in anephric man. Kidney Int 4: 289, 1973PubMedCrossRefGoogle Scholar
  50. 50.
    Williams GH, Bailey GL, Hampers CL, Lauler DP, Merrill JP, Underwood RH, Blair-West JR, Coghlan JP, Denton DA, Scoggins BA, Wright RD: Studies on the metabolism of aldosterone in chronic renal failure and anephric man. Kidney Int 4: 289, 1973CrossRefGoogle Scholar
  51. 51.
    Cope CL, Person J: Aldosterone secretion in severe renal failure. Clin Sci 25: 331, 1963PubMedGoogle Scholar
  52. 52.
    Corvol T, Bertagna X, Bedrossian J: Increases steroid metabolic clearance rate in anephric patients. Acta Endocrinol 75: 756, 1974PubMedGoogle Scholar
  53. 53.
    Weidmann P, Maxwell MH, Lupu AN: Plasma aldosterone in terminal renal failure. Ann Intern Med 78: 13, 1973PubMedGoogle Scholar
  54. 54.
    Alexander EA, Levinsky NG: An extrarenal mechanism of potassium adaptation. J Clin Invest 47: 740, 1968PubMedCrossRefGoogle Scholar
  55. 55.
    Hayes CP Jr, McLead ME, Robinson RR: An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 80: 207, 1967PubMedGoogle Scholar
  56. 56.
    Reed VH, McCaa CS, Bower JD, McCaa RE: Effect of hemodialysis on metabolic clearance rate, plasma concentration and blood production rate of aldosterone in anephric man. J Clin Endocrinol Metabol 36: 773, 1973CrossRefGoogle Scholar
  57. 57.
    Bayard F, Cooke CR, Tiller DJ, Beitins IZ, Kowarski A, Walker WG, Migeon CJ: The regulation of aldosterone secretion in anephric man. J Clin Invest 50: 1585, 1971PubMedCrossRefGoogle Scholar
  58. 58.
    McCaa RE, McCaa CS, Read VH, Bower JD: Influence of hemodialysis on plasma aldosterone concentration in nephrectomized patients. Trans Am Soc Artif Intern Organs 18: 239, 1973Google Scholar
  59. 59.
    Bailey RE, Ford HC: The effect of heparin on sodium conservation and on the plasma concentration, the metabolic clearance and the secretion and excretion rates of aldosterone in normal subjects. Acta Endocrinol 60: 249, 1969PubMedGoogle Scholar
  60. 60.
    Majoor CLH, Schlatmann RJAFM, Jansen AP, Preven H: Excretion pattern and mechanism of diuresis induced by heparin. Clin Chem Acta 5: 591, 1960CrossRefGoogle Scholar
  61. 61.
    Asbach HW, VecSci P, Schuler HW, Gless KH: Serum und Dialysatespiegel von Corticosteroiden bei Langzeit-Hämodialyse. Dtsch Med Wochenschr 98: 1758, 1973PubMedCrossRefGoogle Scholar
  62. 62.
    Deck KA, Siemon G, Sieberth HG, von Bayer H: Cortisolverlust und Plasma 11 Hydroxy-corticosteroid- profil während der Hämodialyse. Verh Dtsch Ges Inn Med 74: 1195, 1968PubMedGoogle Scholar
  63. 63.
    Read VH, Ott CE, Bower JD, McCaa RE, McCaa CS: Clearance of adrenocortical steroids by the artificial kidney. Clin Res 21: 47, 1973Google Scholar
  64. 64.
    Knöchel JP, Scidin DW: The pathophysiology of uremia, in The Kidney, edited by Brenner BM, Rector FC Jr, Philadelphia PA, London, Toronto WB Saunders Company, 1976Google Scholar
  65. 65.
    Mako M, Block M, Starr J, Nielsen K, Friedman E, Rubenstein A: Proinsulin in chronic renal and hepatic failure; a reflection of the relative contribution of the liver and kidney to its metabolism. Clin Res (Abstract) 21: 631, 1973Google Scholar
  66. 66.
    Navalesi R, Alessandro P, Silvia L, Donato L: Insulin metabolism in chronic uremia and in the anephric state: Effect of the dialytic treatment. J Clin Endocrinol Metab 40: 70, 1973CrossRefGoogle Scholar
  67. 67.
    Westervelt FB Jr: Insulin effect in uremia. J Lab Clin Med 74: 79, 1969PubMedGoogle Scholar
  68. 68.
    Andres R, Baltzan MA, Cad er G, Zierler KL: The effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J Clin Invest 41: 108, 1962PubMedCrossRefGoogle Scholar
  69. 69.
    Sagild U, Andersen V, Andreasen PB: Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand 169: 243, 1961PubMedCrossRefGoogle Scholar
  70. 70.
    Bilbrey GL, Carter NW, White MG, Schilling JF, Knöchel JP: Potassium deficiency in chronic renal failure. Kidney Int 4: 423, 1973PubMedCrossRefGoogle Scholar
  71. 71.
    Dzurik R, Krajci-Lazary B: The effect of uremic serum on carbohydrate metabolism in rat diaphram. Experientia 23: 798, 1967PubMedCrossRefGoogle Scholar
  72. 72.
    Relman AS: Metabolic consequences of acid-base disorders. Kidney Int 1: 347, 1972PubMedCrossRefGoogle Scholar
  73. 73.
    Unger RH: Glucagon physiology and pathophysiology N Engl J Med 285: 443, 1971PubMedCrossRefGoogle Scholar
  74. 74.
    Sherwin RS, Basil C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P: Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. J Clin Invest 57: 722, 1975CrossRefGoogle Scholar
  75. 75.
    Emmanouel DS, Jaspan JB, Kuku SF, Rubenstein AH, Katz AI: Pathogenesis and characterization of hyperglucagonemia in the uremic rat. J Clin Invest 58: 1266, 1976PubMedCrossRefGoogle Scholar
  76. 76.
    Bilbrey GL, Faloona GR, White MG, Knöchel JP: Hyperglucagonemia of renal failure. J Clin Invest 53: 841, 1974PubMedCrossRefGoogle Scholar
  77. 77.
    Bilbrey GL, Faloona GR, White MG, Atkins C, Hull AR, Knöchel JP: Hyperglucagonemia in uremia. Reversal by renal transplantation. Ann Int Med 82: 525, 1975PubMedGoogle Scholar
  78. 78.
    Lindsey A, Samteusanio F, Braten J, Faloona GF, Unger RH: Pancreatic alpha cell function in trauma. JAMA 227: 757, 1974PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers bv, The Hague 1979

Authors and Affiliations

  • James P. Knochel

There are no affiliations available

Personalised recommendations